These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20103680)

  • 1. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma.
    Schadler KL; Zweidler-McKay PA; Guan H; Kleinerman ES
    Clin Cancer Res; 2010 Feb; 16(3):848-56. PubMed ID: 20103680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.
    Reddy K; Cao Y; Zhou Z; Yu L; Jia SF; Kleinerman ES
    Angiogenesis; 2008; 11(3):257-67. PubMed ID: 18344025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.
    Yu L; Su B; Hollomon M; Deng Y; Facchinetti V; Kleinerman ES
    Cancer Res; 2010 Feb; 70(4):1334-43. PubMed ID: 20124484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-like ligand 4-Notch signaling regulates bone marrow-derived pericyte/vascular smooth muscle cell formation.
    Stewart KS; Zhou Z; Zweidler-McKay P; Kleinerman ES
    Blood; 2011 Jan; 117(2):719-26. PubMed ID: 20944072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung.
    Zhou Z; Stewart KS; Yu L; Kleinerman ES
    Angiogenesis; 2011 May; 14(2):125-33. PubMed ID: 21184173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels.
    Reddy K; Zhou Z; Schadler K; Jia SF; Kleinerman ES
    Mol Cancer Res; 2008 Jun; 6(6):929-36. PubMed ID: 18567797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
    Reddy K; Zhou Z; Jia SF; Lee TH; Morales-Arias J; Cao Y; Kleinerman ES
    Int J Cancer; 2008 Aug; 123(4):831-7. PubMed ID: 18537159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
    Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.
    Hamdan R; Zhou Z; Kleinerman ES
    Mol Cancer Ther; 2014 Feb; 13(2):483-91. PubMed ID: 24282276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.
    Lee TH; Bolontrade MF; Worth LL; Guan H; Ellis LM; Kleinerman ES
    Int J Cancer; 2006 Aug; 119(4):839-46. PubMed ID: 16557578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in Vivo.
    Bolontrade MF; Zhou RR; Kleinerman ES
    Clin Cancer Res; 2002 Nov; 8(11):3622-7. PubMed ID: 12429654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
    Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
    PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo.
    Zhou Z; Reddy K; Guan H; Kleinerman ES
    Mol Cancer Res; 2007 Nov; 5(11):1125-32. PubMed ID: 18025258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
    Guan H; Zhou Z; Gallick GE; Jia SF; Morales J; Sood AK; Corey SJ; Kleinerman ES
    Mol Cancer Ther; 2008 Jul; 7(7):1807-16. PubMed ID: 18644993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model.
    Chernoguz A; Crawford K; Donovan E; Vandersall A; Berglund C; Cripe TP; Frischer JS
    J Surg Res; 2012 Mar; 173(1):1-9. PubMed ID: 21658718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model.
    Zhou Z; Zhou RR; Guan H; Bucana CD; Kleinerman ES
    Mol Cancer Ther; 2003 Dec; 2(12):1313-9. PubMed ID: 14707272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.
    Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES
    Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.